Next Article in Journal
SGLT2 Inhibitor—Dapagliflozin Attenuates Diabetes-Induced Renal Injury by Regulating Inflammation through a CYP4A/20-HETE Signaling Mechanism
Next Article in Special Issue
Ashwagandha (Withania somnifera)—Current Research on the Health-Promoting Activities: A Narrative Review
Previous Article in Journal
A Comparative Study of Cancer Cells Susceptibility to Silver Nanoparticles Produced by Electron Beam
Previous Article in Special Issue
The Potential of Medicinal Plants and Natural Products in the Treatment of Burns and Sunburn—A Review
 
 
Article

Article Versions Notes

Pharmaceutics 2023, 15(3), 964; https://doi.org/10.3390/pharmaceutics15030964
Action Date Notes Link
article xml file uploaded 16 March 2023 12:07 CET Original file -
article xml uploaded. 16 March 2023 12:07 CET Update -
article pdf uploaded. 16 March 2023 12:07 CET Version of Record https://www.mdpi.com/1999-4923/15/3/964/pdf-vor
article html file updated 16 March 2023 12:08 CET Original file -
article xml file uploaded 21 March 2023 01:33 CET Update -
article xml uploaded. 21 March 2023 01:33 CET Update https://www.mdpi.com/1999-4923/15/3/964/xml
article pdf uploaded. 21 March 2023 01:33 CET Updated version of record https://www.mdpi.com/1999-4923/15/3/964/pdf
article supplementary file uploaded. 21 March 2023 01:33 CET - https://www.mdpi.com/1999-4923/15/3/964#supplementary
article html file updated 21 March 2023 01:34 CET Update -
article html file updated 6 April 2023 20:13 CEST Update https://www.mdpi.com/1999-4923/15/3/964/html
Back to TopTop